Article Details

Proteostasis Therapeutics (NASDAQ:PTI) Rating Increased to Buy at ValuEngine

Retrieved on: 2020-01-27 07:26:15

Tags for this article:

Click the tags to see associated articles and topics

Proteostasis Therapeutics (NASDAQ:PTI) Rating Increased to Buy at ValuEngine. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC boosted its position in shares of Proteostasis Therapeutics by 61.7% in the second quarter. <b>Acadian Asset</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up